NASDAQ:HBIO - US4169061052 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 88.75M | 94.14M | 112.25M | 113.30M | 118.90M | |||
Cost Of Goods | 38.26M | 39.33M | 45.86M | 51.00M | 51.30M | |||
Gross Profit | 50.49M | 54.81M | 66.39M | 62.30M | 67.70M | |||
Operating Expenses | 54.37M | 60.19M | 64.11M | 67.10M | 64.20M | |||
Research and Development | 9.40M | 10.41M | 11.76M | 12.30M | 10.80M | |||
Selling, General, and Administrative Expenses | 39.71M | 43.70M | 46.82M | 48.60M | 47.70M | |||
Operating Income | -3.88M | -5.38M | 2.29M | -4.70M | 3.40M | |||
Interest Income/Expense | -3.30M | -4.80M | -4.22M | -2.50M | -1.50M | |||
Other Income/Expense | -1.30M | -652.00K | -227.00K | 300.00K | -700.00K | |||
Non Recurring Items | -48.47M | -835.00K | -391.00K | -2.20M | -1.30M | |||
Income Before Taxes | -56.95M | -11.66M | -2.56M | -9.20M | -100.00K | |||
Income Tax | 457.00K | 740.00K | 859.00K | 300.00K | 100.00K | |||
Net Income | -57.41M | -12.40M | -3.42M | -9.50M | -300.00K | |||
EBITDA | 2.97M | 1.78M | 9.28M | 2.87M | 11.02M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.30 | -0.28 | -0.08 | -0.23 | -0.01 | |||
Non GAAP EPS | 0.02 | 0.06 | 0.15 | 0.12 | 0.25 | |||
Statistics | ||||||||
Gross Profit Margin | 56.89% | 58.22% | 59.15% | 54.99% | 56.94% | |||
Profit Margin | -64.68% | -13.18% | -3.04% | -8.38% | -0.25% | |||
Operating Profit Margin | -4.37% | -5.71% | 2.04% | -4.15% | 2.86% |
All data in USD